Alyeska Investment Group Portfolio holdings
AUM
$28.2B
This Quarter Return
+4.96%
1 Year Return
+38.86%
3 Year Return
+101.95%
5 Year Return
+160.93%
10 Year Return
+424.53%
AUM
$2.78B
AUM Growth
+$2.78B
(+32%)
Cap. Flow
+$621M
Cap. Flow
% of AUM
22.32%
Top 10 Holdings %
Top 10 Hldgs %
15.19%
Holding
424
New
147
Increased
72
Reduced
41
Closed
136
Top Buys
| 1 |
Bloomin' Brands
BLMN
|
$59.5M |
| 2 |
Pfizer
PFE
|
$32.3M |
| 3 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
$31.3M |
| 4 |
Dentsply Sirona
XRAY
|
$29.3M |
| 5 |
Invesco
IVZ
|
$28.7M |
Top Sells
| 1 |
NRF
NorthStar Realty Finance Corp.
NRF
|
$37.2M |
| 2 |
3M
MMM
|
$36.5M |
| 3 |
Range Resources
RRC
|
$33.3M |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
$26.9M |
| 5 |
Norwegian Cruise Line
NCLH
|
$24.8M |
Sector Composition
| 1 | Healthcare | 17.41% |
| 2 | Industrials | 17.12% |
| 3 | Financials | 14.68% |
| 4 | Energy | 9.77% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Edgewell Personal Care
EPC
$1.1B
| – | – |
-30,114
| Closed | -$2.42M |
|
327
Esperion Therapeutics
ESPR
$490M
| – | – |
-73,970
| Closed | -$1.02M |
|
328
Empire State Realty Trust
ESRT
$1.32B
| – | – |
-119,078
| Closed | -$1.82M |
|
329
Freeport-McMoran
FCX
$66.3B
| – | – |
-50,000
| Closed | -$1.89M |
|
330
FedEx
FDX
$53.2B
| – | – |
-58,500
| Closed | -$8.41M |
|
331
Five Below
FIVE
$8.33B
| – | – |
-50,000
| Closed | -$2.16M |
|
332
Fluor
FLR
$6.93B
| – | – |
-200,000
| Closed | -$16.1M |
|
333
Flowserve
FLS
$6.99B
| – | – |
-180,000
| Closed | -$14.2M |
|
334
VanEck Gold Miners ETF
GDX
$19.6B
| – | – |
-75,000
| Closed | -$1.59M |
|
335
Gevo
GEVO
$394M
| – | – |
-42
| Closed | -$358K |
|
336
Gilead Sciences
GILD
$140B
| – | – |
-110,000
| Closed | -$8.26M |
|
337
Goldman Sachs
GS
$221B
| – | – |
-29,411
| Closed | -$5.21M |
|
338
Hilton Worldwide
HLT
$64.7B
| – | – |
-66,667
| Closed | -$4.45M |
|
339
Harley-Davidson
HOG
$3.57B
| – | – |
-5,000
| Closed | -$346K |
|
340
Heron Therapeutics
HRTX
$204M
| – | – |
-50,000
| Closed | -$445K |
|
341
Incyte
INCY
$17B
| – | – |
-75,000
| Closed | -$3.8M |
|
342
Keurig Dr Pepper
KDP
$39.5B
| – | – |
-81,230
| Closed | -$3.96M |
|
343
Karyopharm Therapeutics
KPTI
$61.4M
| – | – |
-5,000
| Closed | -$1.72M |
|
344
McKesson
MCK
$85.9B
| – | – |
-101,692
| Closed | -$16.4M |
|
345
Medtronic
MDT
$118B
| – | – |
-305,000
| Closed | -$17.5M |
|
346
MetLife
MET
$53.6B
| – | – |
-197,997
| Closed | -$9.52M |
|
347
Meta Platforms (Facebook)
META
$1.85T
| – | – |
-65,000
| Closed | -$3.55M |
|
348
Mohawk Industries
MHK
$8.11B
| – | – |
-160,260
| Closed | -$23.9M |
|
|
349
3M
MMM
$81B
| – | – |
-311,278
| Closed | -$36.5M |
|
350
Monster Beverage
MNST
$62B
| – | – |
-318,756
| Closed | -$3.6M |
|